SkinHealth Systems (SKIN) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 10, 2026, will be held virtually, allowing shareholders to vote and submit questions online.

• Shareholders of record as of April 16, 2026, are eligible to vote on key proposals, including director elections, auditor ratification, and executive compensation.

• Proxy materials are distributed primarily online, with paper copies available upon request, and voting can be done via internet, phone, or mail.

Voting matters and shareholder proposals

• Shareholders will vote on the election of nine directors, ratification of Deloitte & Touche LLP as independent auditor for 2026, and an advisory say-on-pay vote for executive compensation.

• Board recommends voting FOR all director nominees, FOR auditor ratification, and FOR executive compensation.

• Shareholder proposals for the 2027 annual meeting must be submitted by December 25, 2026, with additional advance notice requirements outlined in the bylaws.

Board of directors and corporate governance

• Board consists of nine nominees with diverse backgrounds in healthcare, finance, operations, and governance.

• Majority of directors are independent per Nasdaq and SEC standards; annual board and committee self-evaluations are conducted.

• Board committees include Audit, Compensation, and Nominating & Corporate Governance, each with defined charters and independent membership.

• Board leadership is separated between Chairman and CEO roles, with regular executive sessions and high attendance at meetings.